Attached files
| file | filename |
|---|---|
| EX-99.1 - PRESS RELEASE DATED APRIL 2, 2018 - CBA Florida, Inc. | cbai_ex991.htm |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of
1934
Date of Report (Date of earliest event reported): April 2,
2018
CORD BLOOD AMERICA, INC.
(Exact name of registrant as specified in its
charter)
|
Florida
|
|
000-50746
|
|
90-0613888
|
|
(State
or Other Jurisdiction
|
|
(Commission
|
|
(I.R.S.
Employer
|
|
of
Incorporation)
|
|
File
Number)
|
|
Identification
No.)
|
1857 Helm Drive, Las Vegas, NV 89119
(Address of Principal Executive Office) (Zip
Code)
(702) 914-7250
(Registrant’s telephone number, including area
code)
_______________________________
Copies to:
Anthony Snow
1857 Helm Drive, Las Vegas, NV 89119
Phone: (702) 914-7250
Fax: (702) 914-7251
Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation of the registrant
under any of the following provisions:
☐ Written communications pursuant to Rule 425 under the
Securities Act (17 CFR 230.425)
☐ Soliciting material pursuant to Rule 14a-12 under the
Exchange Act (17 CFR 240.14a-12)
☐ Pre-commencement communications pursuant to Rule
14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐ Pre-commencement communications pursuant to Rule
13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Indicate
by check mark whether the registrant is an emerging growth company
as defined in as defined in Rule 405 of the Securities Act of 1933
(§230.405 of this chapter) or Rule 12b-2 of the Securities
Exchange Act of 1934 (§240.12b-2 of this
chapter).
|
|
Emerging
growth company ☐
If an
emerging growth company, indicate by check mark if the registrant
has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided
pursuant to Section 13(a) of the Exchange Act. ☐
|
On April 2, 2018, Cord Blood America, Inc. (the
“Company”) issued the Press Release attached as Exhibit
99.1 to this Current Report. The Press Release provides details
related to the Company’s financial results and earnings for
the fiscal year ended December 31, 2017 and the three month period
ended December 31, 2017. The information included in Exhibit 99.1
is considered to be “furnished” under the Securities
Exchange Act of 1934.
Item 9.01 Financial Statements and
Exhibits.
(d) Exhibits
The following Exhibits are furnished herewith:
|
Exhibit No.
|
Description
|
|
Press
Release dated April 2, 2018
|
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of
1934, the registrant has duly caused this report to be signed on
its behalf by the undersigned hereunto duly
authorized.
|
|
CORD BLOOD AMERICA, INC.
|
|
|
|
|
|
(Registrant)
|
|
|
|
|
|
|
|
Date:
April 2, 2018
|
By:
|
/s/Anthony
Snow
|
|
|
|
|
Interim
President and Corporate Secretary
|
|